Updated:
20/20 Biolabs, Inc.
20/20 Biolabs, Inc. appears to function as a laboratory incubator for biotechnology startups, providing wet lab and office space along with operational...
20/20 Biolabs, Inc.
20/20 Biolabs, Inc. appears to function as a laboratory incubator for biotechnology startups, providing wet lab and office space along with operational support. The firm's name suggests a focus on vision-related or ophthalmic biotech, though its mandate may extend to broader life sciences. No founding year, named principals, or wealth origin have been confirmed from public sources. The firm's investment posture, if any, is not publicly documented. There are no verified portfolio companies, disclosed asset-class allocations, or known fund structures. Geographic footprint is unknown, and no additional offices or locations have been identified. No data on team size, deployment, or adjacent vehicles (including philanthropic structures) is available in public records. Without a website or LinkedIn presence, operational details remain speculative. 20/20 Biolabs presents as an emerging or niche entity in the life sciences infrastructure space. The lack of public disclosure places it in a pre-transparency phase common among early-stage or privately held service platforms.
General information
Firm type
other
Sector focus
Frequently asked questions
What is 20/20 Biolabs' core business?
Based on the firm's name and limited public records, 20/20 Biolabs appears to be a biotechnology incubator offering wet lab space and operational support to early-stage life sciences companies. The firm may specialize in vision-related biotech but no official mandate has been disclosed.
Is 20/20 Biolabs a family office or an investment firm?
The firm's classification is uncertain. It may be a service-oriented incubator rather than a family office or asset manager. No investment activity, AUM, or fund structures have been publicly reported.
Who founded or leads 20/20 Biolabs?
No named principals or founding team members are available from public sources. The firm lacks a website or LinkedIn presence that would list leadership.
What stage of companies does 20/20 Biolabs work with?
Given the incubator model, the firm likely focuses on seed- or early-stage biotechnology startups. However, no specific stage preferences or portfolio companies have been confirmed.
Where is 20/20 Biolabs headquartered?
The firm's location has not been disclosed in public records. No city, state, or country of operation is confirmed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: